A citation-based method for searching scientific literature

Susanne B Haga, Jivan Moaddeb. Pharmacogenet Genomics 2014
Times Cited: 31







List of co-cited articles
166 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
268
38

Primary care physicians' knowledge of and experience with pharmacogenetic testing.
S B Haga, W Burke, G S Ginsburg, R Mills, R Agans. Clin Genet 2012
160
32


Pharmacogenomics in the clinic.
Mary V Relling, William E Evans. Nature 2015
364
29

PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.
James M Hoffman, Cyrine E Haidar, Mark R Wilkinson, Kristine R Crews, Donald K Baker, Nancy M Kornegay, Wenjian Yang, Ching-Hon Pui, Ulrike M Reiss, Aditya H Gaur,[...]. Am J Med Genet C Semin Med Genet 2014
150
25

Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.
J M Pulley, J C Denny, J F Peterson, G R Bernard, C L Vnencak-Jones, A H Ramirez, J T Delaney, E Bowton, K Brothers, K Johnson,[...]. Clin Pharmacol Ther 2012
269
25

Assessment of the pharmacogenomics educational needs of pharmacists.
Kristen B McCullough, Christine M Formea, Kevin D Berg, Julianna A Burzynski, Julie L Cunningham, Narith N Ou, Maria I Rudis, Joanna L Stollings, Wayne T Nicholson. Am J Pharm Educ 2011
116
22

Clinical pharmacogenetics implementation: approaches, successes, and challenges.
Kristin W Weitzel, Amanda R Elsey, Taimour Y Langaee, Benjamin Burkley, David R Nessl, Aniwaa Owusu Obeng, Benjamin J Staley, Hui-Jia Dong, Robert W Allan, J Felix Liu,[...]. Am J Med Genet C Semin Med Genet 2014
126
22

Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.
S L Van Driest, Y Shi, E A Bowton, J S Schildcrout, J F Peterson, J Pulley, J C Denny, D M Roden. Clin Pharmacol Ther 2014
167
22

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Henry M Dunnenberger, Kristine R Crews, James M Hoffman, Kelly E Caudle, Ulrich Broeckel, Scott C Howard, Robert J Hunkler, Teri E Klein, William E Evans, Mary V Relling. Annu Rev Pharmacol Toxicol 2015
259
22

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.
J A Johnson, L Gong, M Whirl-Carrillo, B F Gage, S A Scott, C M Stein, J L Anderson, S E Kimmel, M T M Lee, M Pirmohamed,[...]. Clin Pharmacol Ther 2011
423
19



Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing.
Mary W Roederer, Marcia Van Riper, John Valgus, George Knafl, Howard McLeod. Per Med 2012
49
16

The potential impact of pharmacogenetic testing on medication adherence.
S B Haga, N M A LaPointe. Pharmacogenomics J 2013
37
16

Delivering pharmacogenetic testing in a primary care setting.
Rachel Mills, Deepak Voora, Bruce Peyser, Susanne B Haga. Pharmgenomics Pers Med 2013
25
20

Insurance coverage policies for personalized medicine.
Andrew Hresko, Susanne B Haga. J Pers Med 2012
59
16

The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.
R A Wilke, L B Ramsey, S G Johnson, W D Maxwell, H L McLeod, D Voora, R M Krauss, D M Roden, Q Feng, R M Cooper-Dehoff,[...]. Clin Pharmacol Ther 2012
217
16

Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.
S A Scott, K Sangkuhl, C M Stein, J-S Hulot, J L Mega, D M Roden, T E Klein, M S Sabatine, J A Johnson, A R Shuldiner. Clin Pharmacol Ther 2013
546
16

A pharmacogenetic versus a clinical algorithm for warfarin dosing.
Stephen E Kimmel, Benjamin French, Scott E Kasner, Julie A Johnson, Jeffrey L Anderson, Brian F Gage, Yves D Rosenberg, Charles S Eby, Rosemary A Madigan, Robert B McBane,[...]. N Engl J Med 2013
501
16

A randomized trial of genotype-guided dosing of warfarin.
Munir Pirmohamed, Girvan Burnside, Niclas Eriksson, Andrea L Jorgensen, Cheng Hock Toh, Toby Nicholson, Patrick Kesteven, Christina Christersson, Bengt Wahlström, Christina Stafberg,[...]. N Engl J Med 2013
541
16

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.
K R Crews, A Gaedigk, H M Dunnenberger, J S Leeder, T E Klein, K E Caudle, C E Haidar, D D Shen, J T Callaghan, S Sadhasivam,[...]. Clin Pharmacol Ther 2014
376
16

The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics.
O Gottesman, S A Scott, S B Ellis, C L Overby, A Ludtke, J-S Hulot, J Hall, K Chatani, K Myers, J L Kannry,[...]. Clin Pharmacol Ther 2013
97
16

Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.
J K Hicks, J J Swen, C F Thorn, K Sangkuhl, E D Kharasch, V L Ellingrod, T C Skaar, D J Müller, A Gaedigk, J C Stingl. Clin Pharmacol Ther 2013
273
12

Pharmacogenomics in a community pharmacy: ACT now.
Lisa Padgett, Shanna O'Connor, Mary Roederer, Howard McLeod, Stefanie Ferreri. J Am Pharm Assoc (2003) 2011
25
16

Physicians' preparedness for integration of genomic and pharmacogenetic testing into practice within a major healthcare system.
Christina G Selkirk, Scott M Weissman, Andy Anderson, Peter J Hulick. Genet Test Mol Biomarkers 2013
81
12

Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program.
Alan R Shuldiner, Kathleen Palmer, Ruth E Pakyz, Tameka D Alestock, Kristin A Maloney, Courtney O'Neill, Shaun Bhatty, Jamie Schub, Casey Lynnette Overby, Richard B Horenstein,[...]. Am J Med Genet C Semin Med Genet 2014
62
12

Delivering a pharmacogenetic service: is there a role for genetic counselors?
Alice Callard, William Newman, Katherine Payne. J Genet Couns 2012
16
25

Development and evaluation of a pharmacogenomics educational program for pharmacists.
Christine M Formea, Wayne T Nicholson, Kristen B McCullough, Kevin D Berg, Melody L Berg, Julie L Cunningham, Julianna A Merten, Narith N Ou, Joanna L Stollings. Am J Pharm Educ 2013
53
12

Feasibility of implementing a comprehensive warfarin pharmacogenetics service.
Edith A Nutescu, Katarzyna Drozda, Adam P Bress, William L Galanter, James Stevenson, Thomas D Stamos, Ankit A Desai, Julio D Duarte, Victor Gordeuk, David Peace,[...]. Pharmacotherapy 2013
52
12

Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
580
12

Implementation of personalized medicine services in community pharmacies: perceptions of independent community pharmacists.
Katelyn M Alexander, Holly S Divine, Cathy R Hanna, Yevgeniya Gokun, Patricia R Freeman. J Am Pharm Assoc (2003) 2014
31
12

Development and use of active clinical decision support for preemptive pharmacogenomics.
Gillian C Bell, Kristine R Crews, Mark R Wilkinson, Cyrine E Haidar, J Kevin Hicks, Donald K Baker, Nancy M Kornegay, Wenjian Yang, Shane J Cross, Scott C Howard,[...]. J Am Med Inform Assoc 2014
127
12


Emerging roles for pharmacists in clinical implementation of pharmacogenomics.
Aniwaa Owusu-Obeng, Kristin W Weitzel, Randy C Hatton, Benjamin J Staley, Jennifer Ashton, Rhonda M Cooper-Dehoff, Julie A Johnson. Pharmacotherapy 2014
79
12

Community pharmacists' experience with pharmacogenetic testing.
Jivan Moaddeb, Rachel Mills, Susanne B Haga. J Am Pharm Assoc (2003) 2015
26
15

The IGNITE network: a model for genomic medicine implementation and research.
Kristin Wiisanen Weitzel, Madeline Alexander, Barbara A Bernhardt, Neil Calman, David J Carey, Larisa H Cavallari, Julie R Field, Diane Hauser, Heather A Junkins, Phillip A Levin,[...]. BMC Med Genomics 2016
125
12

Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.
J S Schildcrout, J C Denny, E Bowton, W Gregg, J M Pulley, M A Basford, J D Cowan, H Xu, A H Ramirez, D C Crawford,[...]. Clin Pharmacol Ther 2012
122
12

Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
P H O'Donnell, N Wadhwa, K Danahey, B A Borden, S M Lee, J P Hall, C Klammer, S Hussain, M Siegler, M J Sorrentino,[...]. Clin Pharmacol Ther 2017
45
12

Pharmacogenomics knowledge for personalized medicine.
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin Pharmacol Ther 2012
922
12

Professional perspectives about pharmacogenetic testing and managing ancillary findings.
Susanne B Haga, Genevieve Tindall, Julianne M O'Daniel. Genet Test Mol Biomarkers 2012
39
9


Development and implementation of a pharmacist-managed clinical pharmacogenetics service.
Kristine R Crews, Shane J Cross, John N McCormick, Donald K Baker, Alejandro R Molinelli, Richard Mullins, Mary V Relling, James M Hoffman. Am J Health Syst Pharm 2011
101
9

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review.
K A Phillips, D L Veenstra, E Oren, J K Lee, W Sadee. JAMA 2001
427
9

SLCO1B1 variants and statin-induced myopathy--a genomewide study.
E Link, S Parish, J Armitage, L Bowman, S Heath, F Matsuda, I Gut, M Lathrop, R Collins. N Engl J Med 2008
9



Pharmacogenomics--drug disposition, drug targets, and side effects.
William E Evans, Howard L McLeod. N Engl J Med 2003
9

Defining the opportunity for pharmacogenetic intervention in primary care.
Gloria R Grice, Terry L Seaton, Abigail M Woodland, Howard L McLeod. Pharmacogenomics 2006
30
10

Medication therapy management: 10 years of experience in a large integrated health care system.
Djenane Ramalho de Oliveira, Amanda R Brummel, David B Miller. J Manag Care Pharm 2010
188
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.